West-Ward Columbus Inc. is recalling 58,096 bottles of Doxycycline Hyclate Tablets, USP (100 mg), a prescription antibiotic used to treat various bacterial infections. Approximately 29,048 50-count bottles and 29,048 500-count bottles are affected because the medication failed dissolution specifications, meaning the tablets may not dissolve properly in the body. This defect can prevent the medication from being absorbed correctly, potentially reducing its effectiveness in treating infections. These products were manufactured by West-Ward Pharmaceuticals Corp. and distributed nationwide throughout the United States.
If the tablets do not dissolve as required, the patient may not receive the full intended dose of the antibiotic, which could lead to treatment failure and allow the bacterial infection to persist or worsen.
Contact healthcare provider and return product for refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.